Skip to content

GRAIL, Inc. GRAL Return on assets

Return on assets at other companies

Abbott logo
AbbottABT
6.5%-11.0pp
Guardant Health logo
Guardant HealthGH
-26.6%-0.7pp
Natera, Inc. logo
Natera, Inc.NTRA
-18.1%+7.1pp
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
-16.5%
Immunome logo
ImmunomeIMNM
-46.7%-9.2pp
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
-9.8%-3.7pp

Other financials

Income statement

See full
Revenue$40.8M+28.1%
Operating income-$135.8M+11.6%
Net income-$93.2M+12.3%
EPS (diluted)-$2.29+26.1%

Balance sheet

See full
Cash & equivalents$76.3M-44.4%
Total debt$51.0M-20.7%
Total equity$2.5B+3.6%
Total assets$2.8B-1.5%

Cash flow

See full
Operating cash flow-$87.0M+8.4%
CapEx$503.0K+711%
Free cash flow-$87.5M+8.0%

Valuation

See full
Market cap$2.62B+145%
Enterprise value$2.6B+164%
P/S16.8×+8.6×

Profitability

See full
Operating margin-348.7%-153pp
Net margin-253.2%-115pp
FCF margin-187.2%-60.4pp

Returns & leverage

See full
Return on equity-16.1%
Debt / equity0.0×
Current ratio11.7×+2.0×

Where this comes from

Calculated from GRAIL, Inc.’s reported figures.

Based on trailing twelve months.

The official record: GRAIL, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about GRAIL, Inc.'s return on assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GRAIL, Inc.'s return on assets?
GRAIL, Inc. (GRAL) reported return on assets of -14% in Q1 2026.
What does return on assets mean?
Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.